Viatris Specialty Drug Patent Portfolio
Viatris Specialty owns 1 orange book drug protected by 6 US patents Given below is the list of Viatris Specialty's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6667344 | Bronchodilating compositions and methods | 22 Jun, 2021 | Expired | 
| US6814953 | Bronchodilating compositions and methods | 22 Jun, 2021 | Expired | 
| US7348362 | Bronchodilating β-agonist compositions and methods | 22 Jun, 2021 | Expired | 
| US7462645 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 | Expired | 
| US8623922 | Bronchodilating Beta-agonist compositions and methods | 22 Jun, 2021 | Expired | 
| US9730890 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 | Expired | 
Latest Legal Activities on Viatris Specialty's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Viatris Specialty.
| Activity | Date | Patent Number | 
|---|---|---|
|   | ||
| Expire Patent  Critical
                   | 20 Sep, 2021 | US9730890 | 
| Maintenance Fee Reminder Mailed  Critical
                   | 05 Apr, 2021 | US9730890 | 
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Jun, 2020 | US7462645 | 
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 Sep, 2019 | US7348362 | 
| Recordation of Patent Grant Mailed  Critical
                   | 15 Aug, 2017 | US9730890 | 
| Patent Issue Date Used in PTA Calculation  Critical
                   | 15 Aug, 2017 | US9730890 | 
| Issue Notification Mailed  Critical
                   | 26 Jul, 2017 | US9730890 | 
| Dispatch to FDC | 19 Jul, 2017 | US9730890 | 
| Filing Receipt - Corrected | 19 Jul, 2017 | US9730890 | 
| Mail-Record Petition Decision of Granted to Accept Delayed Payment of Issue Fee | 11 Jul, 2017 | US9730890 | 
| Record Petition Decision of Granted to Accept Delayed Payment of Issue Fee | 11 Jul, 2017 | US9730890 | 
| O.P. Petition Decision | 11 Jul, 2017 | US9730890 | 
| Mail O.P. Petition Decision | 11 Jul, 2017 | US9730890 | 
| Petition Entered | 17 Feb, 2017 | US9730890 | 
| Supplemental Papers - Oath or Declaration | 17 Feb, 2017 | US9730890 | 
Viatris Specialty's Family Patents
 
 Viatris Specialty Drug List
Given below is the complete list of Viatris Specialty's drugs and the patents protecting them.
1. Perforomist
Perforomist is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status | 
|---|---|---|---|
| US6667344 | Bronchodilating compositions and methods | 22 Jun, 2021 
                  (4 years ago)
                 | Expired | 
| US6814953 | Bronchodilating compositions and methods | 22 Jun, 2021 
                  (4 years ago)
                 | Expired | 
| US7348362 | Bronchodilating β-agonist compositions and methods | 22 Jun, 2021 
                  (4 years ago)
                 | Expired | 
| US7462645 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 
                  (4 years ago)
                 | Expired | 
| US8623922 | Bronchodilating Beta-agonist compositions and methods | 22 Jun, 2021 
                  (4 years ago)
                 | Expired | 
| US9730890 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 
                  (4 years ago)
                 | Expired | 
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Perforomist's drug page
